Glucose-6-Phosphate Dehydrogenase antibody (AA 35-506)
Quick Overview for Glucose-6-Phosphate Dehydrogenase antibody (AA 35-506) (ABIN7596037)
Target
See all Glucose-6-Phosphate Dehydrogenase (G6PD) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 35-506
-
Purpose
- Human G6PD antibody
-
Purification
- Purified
-
Immunogen
- Recombinant human G6PD (35-506aa) purified from E. coli
-
Isotype
- IgG2b kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing cycles
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- Glucose-6-Phosphate Dehydrogenase (G6PD)
-
Alternative Name
- G6PD
-
Background
- Glucose-6-phosphate dehydrogenase (G6PD) is the rate-limiting enzyme of the pentose phosphate pathway, ametabolic pathway that supplies reducing energy to cells by maintaining the level of NADPH. G6PD convertsglucose-6-phosphate into 6-phosphoglucono-delta-lactone and simultaneously produce NADPH. The NADPH inturn maintains the level of glutathione in these cells that helps protect the red blood cells against oxidativedamage. G6PD deficiency cause acute hemolytic anemia.
-
NCBI Accession
- NP_001035810
-
Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones
Target
-